OOIR: Observatory of International Research

Papers

(The TQCC of International Journal of Clinical Oncology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer	87
Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050	87
Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis	60
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma	58
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)	58
Aging, cancer, and antitumor immunity	41
Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis	38
The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study	37
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study	35
Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1	34
Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma	33
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy	31
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan	30
The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan	29
The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases—a literature review	28
Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer	27
Key promoters of tumor hallmarks	26
Soft-tissue sarcoma in adolescents and young adults	25
Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors	24
Frailty is associated with poor prognosis after resection for pancreatic cancer	23
The roles and limitations of bevacizumab in the treatment of ovarian cancer	23
HER2-low breast cancer could be associated with an increased risk of brain metastasis	23
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)	23
The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis	23
Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy	22

Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients	22
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study	21
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis	21
Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy	20
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma	20
Hereditary pancreatic cancer	20
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study	18
Carcinogenesis and management of human papillomavirus-associated cervical cancer	18
Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults af	18
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary	18
Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic	18
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study	17
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1	17
Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy	17
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA	17
The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy	16
The prognostic role of prognostic nutritional index in nasopharyngeal carcinoma: A systematic review and meta-analysis	16
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer	16
TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway	16
Clinicopathological characteristics and prognosis of poorly cohesive cell subtype of gastric cancer	16
The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model	15
Symptoms and signs of parotid tumors and their value for diagnosis and prognosis: a 20-year review at a single institution	15
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib	15
Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and meta-analysis	15
Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body	14
Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis	14
The role of surgery in the treatment of metastatic bone tumor	14
Preoperative nutrition and exercise intervention in frailty patients with gastric cancer undergoing gastrectomy	14
Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases	14
Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study	14
A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG	14
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma	14
LINC00943 is correlated with gastric cancer and regulates cancer cell proliferation and chemosensitivity via hsa-miR-101-3p	14
A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer	14
Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer	14
A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center	14
CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis	14
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium	14
Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer	13
Lymphocyte–C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma	13
Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis	13
General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis	13
Jab1/Cops5: a promising target for cancer diagnosis and therapy	13
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2	13
Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs	13
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma	13
Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study	13
Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis	13
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retro	13
The usefulness of microRNA in urine and saliva as a biomarker of gastroenterological cancer	12

The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer	12
Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021)	12
Clinical and oncologic outcomes of laparoscopic versus open surgery in elderly patients with colorectal cancer: a retrospective multicenter study	12
The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score	12
Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis	12
The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway	12
Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib	12
Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer	12
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis	11
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)	11
Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study	11
The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study	11
Association between human papillomavirus and oral cancer: a literature review	11
Relationship between psoas muscle index and long-term survival in older patients aged ≥ 80 years after endoscopic submucosal dissection for gastric cancer	11
Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis	11
Pelvic reconstruction using an ice-cream cone prosthesis: correlation between the inserted length of the coned stem and surgical outcome	11
SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis	11
Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study	11
Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer	11
Artificial intelligence predicts lymph node metastasis or risk of lymph node metastasis in T1 colorectal cancer	11
Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma	11
Treatments for elderly cancer patients and reforms to social security systems in Japan	11
Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospect	11
A comparative examination of colorectal cancer burden in European Union, 1990–2019: Estimates from Global Burden of Disease 2019 Study	10
Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan	10
Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer	10
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study	10
Intra-corporeal robot-assisted versus open radical cystectomy: a propensity score-matched analysis comparing perioperative and long-term survival outcomes and recurrence patterns	10
Serum zinc deficiency in patients after gastrectomy for gastric cancer	10
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse	10
Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients	10
Extreme leanness, lower skeletal muscle quality, and loss of muscle mass during treatment are predictors of poor prognosis in cervical cancer treated with concurrent chemoradiation therapy	10
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis	10
Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketin	9
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer	9
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab	9
Preoperative predictors of dysphagia after transoral surgery	9
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study	9
Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma	9
Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden	9
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance	9
Preoperative iron status is a prognosis factor for stage II and III colorectal cancer	9
The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma	9
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048	9
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia	9
Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib	9
Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location	9
Predicting short-term life expectancy of patients with end-stage gastric cancer using Onodera’s prognostic nutritional index	9
High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT	9
APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients	9
A novel clinically-oriented classification of fine-needle aspiration cytology for salivary gland tumors: a 20-year retrospective analysis of 1175 patients	9
Contribution of chemotherapy to improved prognosis in stage 4 gastric cancer: trend analysis of a regional population-based cancer registry in Japan	9
Clinical effectiveness of surgical treatment after lenvatinib administration for hepatocellular carcinoma	9
Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients	9
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study	9
Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study	9
Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis	9
Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients	9
Percutaneous cryoablation combined with prior transcatheter arterial embolization for renal cell carcinomas of 3 cm or larger: a prospective study	9
Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience	9
Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer	9
Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan	8
Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data	8
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis	8
An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors	8
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial	8
Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective o	8
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801	8
Prognostic value of tumor deposits in locally advanced rectal cancer: a retrospective study with propensity score matching	8
Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer	8
Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy	8
Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas	8
Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan	8
Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, Japan	8
Hsa_circ_0003195 as a biomarker for diagnosis and prognosis of gastric cancer	8
Adolescent and young adult brain tumors: current topics and review	8
Prognostic impact of bone metastatic volume beyond vertebrae and pelvis in patients with metastatic hormone-sensitive prostate cancer	7
Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents	7
Epidemiology and prognosis of lymphoepithelioma-like carcinoma: a comprehensive analysis of surveillance, epidemiology, and end results (SEER) database	7
A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer	7

The ‘best friend effect’: a promising tool to encourage HPV vaccination in Japan	7
Prognostic significance of peritoneal cytology in low-risk endometrial cancer: comparison of laparoscopic surgery and laparotomy	7
Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma	7
Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial	7
The tumor suppressor function of hsa_circ_0006282 in gastric cancer through PTEN/AKT pathway	7
Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis	7
Status of cervical cancer screening among adolescents and young adults (AYA) in Japan	7
Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis	7
Tumor–stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade	6
Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression	6
Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients	6
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma	6
Contributions of HOTAIR polymorphisms to the susceptibility of cancer	6
Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up	6
Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with	6
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1	6
Current status of AYA-generation breast cancer: trends worldwide and in Japan	6
Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy	6
Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer	6
Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma	6
Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck	6
Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study	6
Relationship between diverting stoma and adjuvant chemotherapy in patients with rectal cancer: a nationwide study using the National Database of Health Insurance Claims and Specific Health Checkups of	6
The correlation of immunoscore and frailty in colorectal cancer	6
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study	6
Survival benefit of adjuvant chemotherapy in elderly patients with colon cancer: a systematic review and meta-analysis	6
Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer	6
Acid-suppressive agents and survival outcomes in patients with cancer: a systematic review and meta-analysis	6
The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study	6
Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology	6
A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)	6
Relative dose intensity and 1-year psoas muscle index reduction rate as prognostic factors in gastric cancer patients with postoperative adjuvant chemotherapy	6
Prognostic factors for cytology-positive gastric cancer: a multicenter retrospective analysis	6
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research	6
Health care professionals’ experiences of dealing with cancer cachexia	6
4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study	6
Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin–bilirubin grade	6
Systematic surveillance of immune-related adverse events in clinical practice and impact of subsequent steroid medication on survival outcomes	6
Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study	6
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study	6
Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan	6
Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy	6
Current state of fertility preservation for adolescent and young adult patients with gynecological cancer	6
Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024	6
Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study	6
Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan	6
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?	6
Robotic systems in interventional oncology: a narrative review of the current status	6
Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study	6
Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma	6
Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes	6
Performance of Idylla™ RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer	6
Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer	6
Adjuvant radiotherapy improves overall survival when added to surgery and chemotherapy for uterine carcinosarcoma: a surveillance, epidemiology, and end results analysis	5
Improved oncologic outcomes with increase of laparoscopic surgery in modified complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer: results of 1191 consecutive patients dur	5
Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101)	5
Preoperative transferrin level is a novel indicator of short- and long-term outcomes after esophageal cancer surgery	5
Opioids for the management of dyspnea in cancer patients: a systematic review and meta-analysis	5
Current status of CAR-T cell therapy for pediatric hematologic malignancies	5
The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcoma	5
Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched study	5
A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study	5
Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022	5
Recurrence of initially localized appendiceal mucinous neoplasms after radical resection: survey analysis and literature review	5
Response to first-line chemotherapy regimen is associated with efficacy of ımmune checkpoint blockade therapies in patients with metastatic urothelial carcinoma	5
Modified albumin–bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients	5
Elective neck dissection for T3–T4N0 laryngeal carcinoma: evidence from Japan’s National Head and Neck Cancer Registry	5
Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling	5
Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study	5
Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in Japan	5
Prognostic impact of HER2-low expression in HER2-negative breast cancer under different hormone receptor status	5
Risk factors of mFOLFOX6-induced hyperammonemia in patients with colorectal cancer: an observational study	5
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022	5
Development and external validation of a nomogram for predicting the effect of tumor size on cancer-specific survival of resected gallbladder cancer: a population-based study	5
The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma	5
Insight into autophagy in platinum resistance of cancer	5
Potential intrinsic subtype dependence on the association between metformin use and survival in surgically resected breast cancer: a Korean national population-based study	5
Changes of cancer diagnosis disclosure to children in Japan in the last 20 years	5
Lower accuracy of cytological screening for high-grade squamous intraepithelial neoplasia in women over 50 years of age in Japan	5
Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study	5
Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer	5
Risk assessment of multi-factorial complications after transrectal ultrasound-guided prostate biopsy: a single institutional retrospective cohort study	5
Association between financial toxicity and health-related quality of life of patients with gynecologic cancer	5
The impact of the American Society of Anesthesiology-Physical Status classification system on the treatment and prognosis of patients with esophageal cancer undergoing esophagectomy	5
Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate	5
EGFL7 as a novel therapeutic candidate regulates cell invasion and anoikis in colorectal cancer through PI3K/AKT signaling pathway	5
piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies	5
Locomotive syndrome in cancer patients: a new role of orthopaedic surgeons as a part of comprehensive cancer care	5
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021	5
Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab	5
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study	5
Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center	5
Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy	5
Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy–refractory extensive-stage SCLC: a real-world retrospective study	5
A prospective observational study of postoperative adjuvant chemotherapy for non-small cell lung cancer in elderly patients (≥ 75 years)	5